Beyond conventional therapy: Synthesis of multifunctional nanoparticles for rheumatoid arthritis therapy

Rheumatoid arthritis (RA) is a persistent inflammatory illness that causes joint destruction and dysfunction due to the activation of macrophages and the generation of reactive oxygen species. Current therapy choices frequently limit the effectiveness of targeting the inflammatory areas. To reduce i...

Full description

Saved in:
Bibliographic Details
Main Author: Ma Xinran
Format: Article
Language:English
Published: De Gruyter 2024-10-01
Series:Nanotechnology Reviews
Subjects:
Online Access:https://doi.org/10.1515/ntrev-2024-0096
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850180991018074112
author Ma Xinran
author_facet Ma Xinran
author_sort Ma Xinran
collection DOAJ
description Rheumatoid arthritis (RA) is a persistent inflammatory illness that causes joint destruction and dysfunction due to the activation of macrophages and the generation of reactive oxygen species. Current therapy choices frequently limit the effectiveness of targeting the inflammatory areas. To reduce inflammation and oxidative stress in RA, this research will create and assess multifunctional nanoparticles that selectively target inflammatory cells and deliver therapeutic medicines. Tannic acid, ferric chloride hexahydrate, methotrexate (MTX), and bovine serum albumin were conjugated using sonication and centrifugation to create the nanoparticles. Folic acid was added to improve the ability to target. Transmission electron microscopy, dynamic light scattering (DLS), UV-vis spectroscopy, and in vitro release experiments were used to characterize the nanoparticles. RAW 264.7 macrophage cells were used to test the cellular uptake of the nanoparticles using confocal microscopy and fluorescence-activated cell sorting (FACS). TFMBP-FA achieved 65.56%, and TFMBP reached 68.96%, indicating a high drug delivery rate for the synthesized nanoparticles. Confocal microscopy showed that the TFMBP-FA group had a greater density of fluorescent markers, indicating that the cells effectively targeted and absorbed the inflammatory environment. These results imply that the created nanoparticles may improve how medications are delivered during RA therapy.
format Article
id doaj-art-7e8a6852d4304f3bb818c6bc99cafe5b
institution OA Journals
issn 2191-9097
language English
publishDate 2024-10-01
publisher De Gruyter
record_format Article
series Nanotechnology Reviews
spelling doaj-art-7e8a6852d4304f3bb818c6bc99cafe5b2025-08-20T02:18:00ZengDe GruyterNanotechnology Reviews2191-90972024-10-011313289310.1515/ntrev-2024-0096Beyond conventional therapy: Synthesis of multifunctional nanoparticles for rheumatoid arthritis therapyMa Xinran0The Spence School, New York, NY, 10128, United StatesRheumatoid arthritis (RA) is a persistent inflammatory illness that causes joint destruction and dysfunction due to the activation of macrophages and the generation of reactive oxygen species. Current therapy choices frequently limit the effectiveness of targeting the inflammatory areas. To reduce inflammation and oxidative stress in RA, this research will create and assess multifunctional nanoparticles that selectively target inflammatory cells and deliver therapeutic medicines. Tannic acid, ferric chloride hexahydrate, methotrexate (MTX), and bovine serum albumin were conjugated using sonication and centrifugation to create the nanoparticles. Folic acid was added to improve the ability to target. Transmission electron microscopy, dynamic light scattering (DLS), UV-vis spectroscopy, and in vitro release experiments were used to characterize the nanoparticles. RAW 264.7 macrophage cells were used to test the cellular uptake of the nanoparticles using confocal microscopy and fluorescence-activated cell sorting (FACS). TFMBP-FA achieved 65.56%, and TFMBP reached 68.96%, indicating a high drug delivery rate for the synthesized nanoparticles. Confocal microscopy showed that the TFMBP-FA group had a greater density of fluorescent markers, indicating that the cells effectively targeted and absorbed the inflammatory environment. These results imply that the created nanoparticles may improve how medications are delivered during RA therapy.https://doi.org/10.1515/ntrev-2024-0096rheumatoid arthritistannic acid-iron based nanoparticleactive targeted therapyinflammationros scavenging
spellingShingle Ma Xinran
Beyond conventional therapy: Synthesis of multifunctional nanoparticles for rheumatoid arthritis therapy
Nanotechnology Reviews
rheumatoid arthritis
tannic acid-iron based nanoparticle
active targeted therapy
inflammation
ros scavenging
title Beyond conventional therapy: Synthesis of multifunctional nanoparticles for rheumatoid arthritis therapy
title_full Beyond conventional therapy: Synthesis of multifunctional nanoparticles for rheumatoid arthritis therapy
title_fullStr Beyond conventional therapy: Synthesis of multifunctional nanoparticles for rheumatoid arthritis therapy
title_full_unstemmed Beyond conventional therapy: Synthesis of multifunctional nanoparticles for rheumatoid arthritis therapy
title_short Beyond conventional therapy: Synthesis of multifunctional nanoparticles for rheumatoid arthritis therapy
title_sort beyond conventional therapy synthesis of multifunctional nanoparticles for rheumatoid arthritis therapy
topic rheumatoid arthritis
tannic acid-iron based nanoparticle
active targeted therapy
inflammation
ros scavenging
url https://doi.org/10.1515/ntrev-2024-0096
work_keys_str_mv AT maxinran beyondconventionaltherapysynthesisofmultifunctionalnanoparticlesforrheumatoidarthritistherapy